Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation

Drug targeting and nanomedicine are different strategies for improving the delivery of drugs to their target. Several antibodies, immuno-drug conjugates and nanomedicines are already approved and used in clinics, demonstrating the potential of such approaches, including the recent examples of the DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvati, Anna, Poelstra, Klaas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777931/
https://www.ncbi.nlm.nih.gov/pubmed/35057111
http://dx.doi.org/10.3390/pharmaceutics14010217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777931/
https://www.ncbi.nlm.nih.gov/pubmed/35057111
http://dx.doi.org/10.3390/pharmaceutics14010217

Ejemplares similares